Drug Profile
Sinitrodil
Alternative Names: ITF 296Latest Information Update: 06 Mar 2008
Price :
$50
*
At a glance
- Originator Italfarmaco
- Class Organic nitrates; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Isolated systolic hypertension; Myocardial ischaemia
Most Recent Events
- 06 Mar 2008 Discontinued - Clinical-Phase-Unknown for Isolated systolic hypertension in Italy (PO)
- 06 Mar 2008 Discontinued - Phase-II for Angina pectoris in Italy (IV)
- 06 Mar 2008 Discontinued - Phase-II for Myocardial ischaemia in European Union (unspecified route)